TP53 and non-small cell lung carcinoma: In this study, RG7388 exhibited excellent therapeutic effect against the wtTP53‐RTK NSCLC, suggesting the genetic status of TP53 and RTK are crucial for the efficacy of MDM2 inhibitor.